PCM
BLU

Prelude Capital Management’s BELLUS Health Inc. BLU Stock Holding History

Prelude Capital Management’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-466
Closed -$4K – 2184
2019
Q4 		$4K Buy
466
+31
+7% +$212 ﹤0.01% 1796
2019
Q3 		$3K Buy
+435
New +$3.07K ﹤0.01% 1609

Other funds holding BLU

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Prelude Capital Management's BLU Position: Q1 2020 in Review

Prelude Capital Management sold out of BELLUS Health Inc. (BLU) in Q1 2020, closing a stake of 466 shares — an estimated $4K sold.

Prelude Capital Management first reported a position in BLU in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 48 funds tracked by Wall St. Rank hold BLU as of Q1 2020.

  • Prelude Capital Management reported no remaining BELLUS Health Inc. position as of Q1 2020 after selling out during the quarter.
  • Prelude Capital Management sold 466 BELLUS Health Inc. shares in Q1 2020, an estimated $4K.
  • Prelude Capital Management first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 2 quarters.
  • Prelude Capital Management's BELLUS Health Inc. position peaked at $4K in Q4 2019.
  • 48 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.